Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06711679 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06711679 · ClinicalTrials.gov record · last posted 2024-12-02

Exploring the Minimum Effective Concentration and Volume of Ropivacaine for Sacral Plexus Anesthesia

StatusEnrolling by Invitation
PhasePhase 4
SponsorYilin Zhao
Started2024-05-10
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 2, 2024 (before its estimated December 20, 2024 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
The goal of this clinical trial is to explore the minimum effective concentration and volume of ropivacaine for sacral plexus anesthesia. The main questions it aims to answer are: * The distribution of different volumes of ropivacaine after caudal anesthesia * The blockade level after caudal anesthesia with varying doses * The minimum effective concentration of ropivacaine among pediatric patients of different age groups Researchers will inject different doses or concentrations of ropivacaine into the caudal canal to observe the drug's spread range, the level of blockade, and the duration of its effect. Participants will: * Undergo magnetic resonance imaging (MRI) examinations before and after caudal anesthesia * Will be detected the blockade level after caudal anesthesia
Trial Details
NCT Number NCT06711679
Lead Sponsor Yilin Zhao
Collaborators: Henan Provincial People's Hospital, Wuhan Children's Hospital
Conditions Pediatric ALL
Enrollment 180 participants
Start Date 2024-05-10
Primary Completion 2024-12-20 (estimated)
Study Completion 2026-03-20 (estimated)
Updated on ClinicalTrials.gov 2024-12-02